Trials / Completed
CompletedNCT02062073
Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion
A Randomized, Controlled Study to Evaluate the Sensitizing Potential of Abametapir Lotion in Healthy Volunteers Using a Repeat Insult Patch Test Design
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 238 (actual)
- Sponsor
- Dr. Reddy's Laboratories Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Purpose of this study will be to determine the potential of abametapir lotion to induce sensitization by repeated topical application to the healthy skin of humans under controlled conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Abametapir Lotion 0.74% w/w | |
| OTHER | 0.1% sodium lauryl sulfate | |
| OTHER | saline 0.9% | |
| OTHER | Vehicle Lotion |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-03-01
- Completion
- 2014-06-01
- First posted
- 2014-02-13
- Last updated
- 2020-04-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02062073. Inclusion in this directory is not an endorsement.